The Case for  -Adrenergic Blockade as Prophylaxis Against Perioperative Cardiovascular Morbidity and Mortality
Craig H. Selzman, MD;
Stephanie A. Miller, MD;
Michael A. Zimmerman, MD;
Alden H. Harken, MD
Arch Surg. 2001;136:286-290.
Perioperative morbidity and mortality are frequently cardiac in origin. Many studies have prospectively attempted to define risk factors for cardiac ischemic events. Although we can now identify high-risk patients, optimal cardioprotective management strategies remain unclear. Treatment with  -adrenergic antagonists decreases myocardial oxygen consumption and is generally well tolerated. This article reviews the physiologic and clinical basis for using these agents as prophylaxis against cardiovascular events in high-risk surgical patients.
From the Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado Health Sciences Center, Denver.
RELATED ARTICLES
This Month in Archives of Surgery
Arch Surg. 2001;136(3):259.
FULL TEXT
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(3):361.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Brain death leads to abnormal contractile properties of the human donor right ventricle
Harken
J. Thorac. Cardiovasc. Surg. 2006;132:10-11.
FULL TEXT
Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery
Lindenauer et al.
NEJM 2005;353:349-361.
ABSTRACT
| FULL TEXT
The effect of perioperative beta-blockers on patients undergoing noncardiac surgery - is the answer in?/L'effet des beta-blo-quants perioperatoires sur les patients de chirurgie non cardiaque - avons-nous la reponse ?
Devereaux et al.
Canadian J. Anesthesia 2004;51:749-755.
FULL TEXT
Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?
Geraci and Haan
Ann. Thorac. Surg. 2002;74:1727-1732.
ABSTRACT
| FULL TEXT
|
